Early hGH Treatment of SGA Infants to Prevent Irreversible Neurologic and Psychological Damage and Sequelae

NCT02326610 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

20

Enrollment

OTHER_GOV

Sponsor class

Conditions

Infant, Small for Gestational Age
Growth Hormone Treatment
Infant, Premature, Diseases

Interventions

DRUG: Human growth hormone,ZOMACTON® (somatropin)

Sponsor

Tel-Aviv Sourasky Medical Center